株探米国株
日本語 英語
エドガーで原本を確認する
false000070754900007075492025-10-222025-10-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
 Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October 22, 2025
  LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware   0-12933   94-2634797
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification Number)
4650 Cushing Parkway
Fremont, California 94538
(Address of principal executive offices including zip code)
(510) 572-0200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share LRCX The Nasdaq Stock Market
(Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company      ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                      ☐


Table of Contents
 
Item 2.02.    Results of Operations and Financial Condition  
Item 9.01.    Financial Statements and Exhibits  
SIGNATURES  
EX-99.1


 Item 2.02. Results of Operations and Financial Condition
On October 22, 2025, Lam Research Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended September 28, 2025, the text of which is attached hereto as Exhibit 99.1.
The information in this item of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, the information in this item of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
 Item 9.01. Financial Statements and Exhibits
(d) Exhibits
99.1
104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 22, 2025
LAM RESEARCH CORPORATION
(Registrant)
  /s/ Douglas R. Bettinger
  Douglas R. Bettinger
  Executive Vice President and Chief Financial Officer
  (Principal Financial Officer)
 


EX-99.1 2 lrcx_exhibitx991xq1x2026.htm EX-99.1 Document

Exhibit 99.1
FOR IMMEDIATE RELEASE        
Lam Research Corporation Reports Financial Results for the Quarter Ended September 28, 2025
FREMONT, Calif., October 22, 2025 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended September 28, 2025 (the “September 2025 quarter”).
Highlights for the September 2025 quarter were as follows:
•Revenue of $5.32 billion.
•U.S. GAAP gross margin of 50.4%, U.S. GAAP operating income as a percentage of revenue of 34.4%, and U.S. GAAP diluted EPS of $1.24.
•Non-GAAP gross margin of 50.6%, non-GAAP operating income as a percentage of revenue of 35.0%, and non-GAAP diluted EPS of $1.26.
Key Financial Data for the Quarters Ended
September 28, 2025 and June 29, 2025
(in thousands, except per-share data, percentages, and basis points) 
U.S. GAAP
  September 2025 June 2025 Change Q/Q
Revenue $ 5,324,173  $ 5,171,393  + 3%
Gross margin as percentage of revenue 50.4  % 50.1  % + 30 bps
Operating income as percentage of revenue 34.4  % 33.7  % + 70 bps
Diluted EPS $ 1.24  $ 1.35  - 8%
Non-GAAP
  September 2025 June 2025 Change Q/Q
Revenue $ 5,324,173  $ 5,171,393  + 3%
Gross margin as percentage of revenue 50.6  %   50.3  % + 30 bps
Operating income as percentage of revenue 35.0  %   34.4  % + 60 bps
Diluted EPS $ 1.26    $ 1.33  - 5%

U.S. GAAP Financial Results
For the September 2025 quarter, revenue was $5,324 million, gross margin was $2,685 million, or 50.4% of revenue, operating expenses were $856 million, operating income was 34.4% of revenue, and net income was $1,569 million, or $1.24 per diluted share on a U.S. GAAP basis. This compares to revenue of $5,171 million, gross margin of $2,590 million, or 50.1% of revenue, operating expenses of $849 million, operating income of 33.7% of revenue, and net income of $1,720 million, or $1.35 per diluted share, for the quarter ended June 29, 2025 (the “June 2025 quarter”).
Non-GAAP Financial Results
For the September 2025 quarter, non-GAAP gross margin was $2,694 million, or 50.6% of revenue, non-GAAP operating expenses were $832 million, non-GAAP operating income was 35.0% of revenue, and non-GAAP net income was $1,605 million, or $1.26 per diluted share. This compares to non-GAAP gross margin of $2,601 million, or 50.3% of revenue, non-GAAP operating expenses of $822 million, non-GAAP operating income of 34.4% of revenue, and non-GAAP net income of $1,698 million, or $1.33 per diluted share, for the June 2025 quarter.

“Lam's innovations are helping our customers address major AI-driven semiconductor manufacturing inflections,” said Tim Archer, Lam Research's President and Chief Executive Officer. “We are executing well in an environment of tremendous opportunity, and with our expanding portfolio of products and solutions across critical device segments, we are strongly positioned for continued growth.”




Balance Sheet and Cash Flow Results
Cash, cash equivalents, and restricted cash balances increased to $6.7 billion at the end of the September 2025 quarter compared to $6.4 billion at the end of the June 2025 quarter. The increase was primarily the result of cash generated from operating activities, partially offset by cash deployed for capital return activities,and capital expenditures during the quarter.
Deferred revenue at the end of the September 2025 quarter increased to $2.77 billion compared to $2.68 billion as of the end of the June 2025 quarter. Lam's deferred revenue balance does not include shipments to customers in Japan, to whom control does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $131 million as of September 28, 2025 and $342 million as of June 29, 2025.
Revenue
The geographic distribution of revenue during the September 2025 quarter is shown in the following table:
Region Revenue
China 43%
Taiwan 19%
Korea 15%
Japan 10%
United States 6%
Southeast Asia 5%
Europe 2%
The following table presents revenue disaggregated between systems and customer support-related revenue:
Three Months Ended
September 28,
2025
June 29,
2025
September 29,
2024
(In thousands)
Systems revenue $ 3,547,565  $ 3,437,625  $ 2,392,730 
Customer support-related revenue and other 1,776,608  1,733,768  1,775,246 
$ 5,324,173  $ 5,171,393  $ 4,167,976 
Systems revenue includes sales of new leading-edge equipment in deposition, etch, and other wafer fabrication markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook
For the quarter ended December 28, 2025, Lam is providing the following guidance:
U.S. GAAP Reconciling Items Non-GAAP
Revenue $5.20 Billion +/- $300 Million $5.20 Billion +/- $300 Million
Gross margin as a percentage of revenue 48.4% +/- 1% $ 2.7  Million 48.5% +/- 1%
Operating income as a percentage of revenue 32.9% +/- 1% $ 3.0  Million 33.0% +/- 1%
Net income per diluted share $1.15 +/- $0.10 $ 3.5  Million $1.15 +/- $0.10
Diluted share count 1.26 Billion 1.26 Billion
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or realized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

•Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $2.7 million.




•Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $3.0 million.

•Net income per diluted share - amortization related to intangible assets acquired though business combinations, $3.0 million; amortization of debt discounts, $0.7 million; and associated tax benefit for non-GAAP items ($0.2 million); totaling $3.5 million.
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the September 2025 and June 2025 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax effect of non-GAAP items. In addition, the September 2025 quarter excludes the impairment of long-lived assets and income tax expense from a change in tax law and the June 2025 quarter excludes the income tax benefit on conclusion of certain tax matters related to a prior business combination.
Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at https://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; the benefits of our products; industry opportunities; our execution; our competitive positioning; and our prospects for growth. Some factors that may affect these forward-looking statements include: business, economic, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; trade regulations, export controls, tariffs, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; supply chain cost increases, tariffs, export controls and other inflationary pressures have impacted and may continue to impact our profitability; supply chain disruptions, export controls or manufacturing capacity constraints may limit our ability to manufacture and sell our products; and natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or other events beyond our control may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10-K for the fiscal year ended June 29, 2025. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.
Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX)
Consolidated Financial Tables Follow.
 ###





 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited) 
  Three Months Ended
  September 28,
2025
June 29,
2025
September 29,
2024
Revenue $ 5,324,173  $ 5,171,393  $ 4,167,976 
Cost of goods sold 2,639,294  2,581,684  2,165,293 
Gross margin 2,684,879  2,589,709  2,002,683 
Gross margin as a percent of revenue 50.4  % 50.1  % 48.0  %
Research and development 576,446  580,178  495,358 
Selling, general and administrative 279,345  268,403  243,128 
Total operating expenses 855,791  848,581  738,486 
Operating income 1,829,088  1,741,128  1,264,197 
Operating income as a percent of revenue 34.4  % 33.7  % 30.3  %
Other income (expense), net 30,074  37,853  30,081 
Income before income taxes 1,859,162  1,778,981  1,294,278 
Income tax expense (290,502) (58,893) (177,834)
Net income $ 1,568,660  $ 1,720,088  $ 1,116,444 
Net income per share:
Basic $ 1.24  $ 1.35  $ 0.86 
Diluted $ 1.24  $ 1.35  $ 0.86 
Number of shares used in per share calculations:
Basic 1,264,446  1,274,279  1,299,236 
Diluted 1,269,313  1,276,933  1,304,066 
Cash dividend declared per common share $ 0.26  $ 0.23  $ 0.23 
 





 LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
 
September 28,
2025
June 29,
2025
September 29,
2024
(unaudited) (1) (unaudited)
ASSETS
Cash and cash equivalents $ 6,693,046  $ 6,390,659  $ 6,067,471 
Accounts receivable, net 3,633,034  3,378,071  2,937,217 
Inventories 4,095,054  4,307,991  4,209,878 
Prepaid expenses and other current assets 385,580  440,274  277,802 
Total current assets 14,806,714  14,516,995  13,492,368 
Property and equipment, net 2,510,531  2,428,744  2,214,269 
Goodwill and intangible assets 1,826,950  1,808,685  1,758,344 
Other assets 2,756,016  2,590,836  2,067,508 
Total assets $ 21,900,211  $ 21,345,260  $ 19,532,489 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt and finance lease obligations $ 754,363  $ 754,311  $ 504,682 
Other current liabilities 5,953,547  5,814,114  4,837,986 
Total current liabilities 6,707,910  6,568,425  5,342,668 
Long-term debt and finance lease obligations 3,729,580  3,730,194  4,479,087 
Income taxes payable 646,044  603,412  664,717 
Other long-term liabilities 623,925  581,610  574,126 
Total liabilities 11,707,459  11,483,641  11,060,598 
Stockholders’ equity (2) 10,192,752  9,861,619  8,471,891 
Total liabilities and stockholders’ equity $ 21,900,211  $ 21,345,260  $ 19,532,489 
 
(1) Derived from audited financial statements.
(2)
Common shares issued and outstanding were 1,259,176 as of September 28, 2025, 1,268,740 as of June 29, 2025, and 1,291,958 as of September 29, 2024.
 





 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
  Three Months Ended
  September 28,
2025
June 29,
2025
September 29,
2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 1,568,660  $ 1,720,088  $ 1,116,444 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 101,644  98,439  94,295 
Deferred income taxes (62,875) (151,679) (108,722)
Equity-based compensation expense 97,241  94,286  80,011 
Other, net (1,890) 14,240  (457)
Changes in operating assets and liabilities 76,184  778,814  386,900 
Net cash provided by operating activities 1,778,964  2,554,188  1,568,471 
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets (185,121) (172,191) (110,588)
Other, net (927) 42,940  37 
Net cash used for investing activities (186,048) (129,251) (110,551)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt, including finance lease obligations and payments for debt issuance costs (1,417) (1,485) (934)
Treasury stock purchases, including excise tax payments (975,791) (1,292,277) (997,035)
Dividends paid (291,981) (295,207) (260,985)
Reissuance of treasury stock related to employee stock purchase plan —  79,556  — 
Proceeds from issuance of common stock, net issuance costs —  696  (43)
Other, net (12,449) (820) (324)
Net cash used for financing activities (1,281,638) (1,509,537) (1,259,321)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (7,059) 29,284  22,682 
Net change in cash, cash equivalents, and restricted cash 304,219  944,684  221,281 
Cash, cash equivalents, and restricted cash at beginning of period (1)
6,407,656  5,462,972  5,850,803 
Cash, cash equivalents, and restricted cash at end of period (1)
$ 6,711,875  $ 6,407,656  $ 6,072,084 

(1) Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets





 
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended
September 28,
2025
June 29,
2025
Revenue $ 5,324,173  $ 5,171,393 
Gross margin $ 2,693,582  $ 2,600,952 
Gross margin as percentage of revenue 50.6  % 50.3  %
Operating expenses $ 831,916  $ 822,375 
Operating income $ 1,861,666  $ 1,778,577 
Operating income as a percentage of revenue 35.0  % 34.4  %
Net income $ 1,604,597  $ 1,697,716 
Net income per diluted share $ 1.26  $ 1.33 
Shares used in per share calculation - diluted 1,269,313  1,276,933 

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited) 
Three Months Ended
September 28,
2025
June 29,
2025
U.S. GAAP net income $ 1,568,660  $ 1,720,088 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 2,687  2,687 
Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold 6,016  8,556 
EDC related liability valuation increase - research and development 10,828  15,401 
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 538  538 
EDC related liability valuation increase - selling, general and administrative 7,219  10,267 
Impairment of long-lived assets - selling, general and administrative 5,290  — 
Amortization of note discounts - other income (expense), net 695  689 
Gain on EDC related asset - other income (expense), net (23,088) (34,102)
Net income tax benefit on non-GAAP items (1,698) (1,668)
Income tax expense from a change in tax law 27,450  — 
Income tax benefit on the conclusion of certain tax matters —  (24,740)
Non-GAAP net income $ 1,604,597  $ 1,697,716 
Non-GAAP net income per diluted share $ 1.26  $ 1.33 
U.S. GAAP net income per diluted share $ 1.24  $ 1.35 
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 1,269,313  1,276,933 

 





Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited) 
Three Months Ended
September 28,
2025
June 29,
2025
U.S. GAAP gross margin $ 2,684,879  $ 2,589,709 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations 2,687  2,687 
EDC related liability valuation increase 6,016  8,556 
Non-GAAP gross margin $ 2,693,582  $ 2,600,952 
U.S. GAAP gross margin as a percentage of revenue 50.4  % 50.1  %
Non-GAAP gross margin as a percentage of revenue 50.6  % 50.3  %
U.S. GAAP operating expenses $ 855,791  $ 848,581 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations (538) (538)
EDC related liability valuation increase (18,047) (25,668)
Impairment of long-lived assets (5,290) — 
Non-GAAP operating expenses $ 831,916  $ 822,375 
U.S. GAAP operating income $ 1,829,088  $ 1,741,128 
Non-GAAP operating income $ 1,861,666  $ 1,778,577 
U.S. GAAP operating income as percent of revenue 34.4  % 33.7  %
Non-GAAP operating income as a percent of revenue 35.0  % 34.4  %
 
Lam Research Corporation Contacts:
Ram Ganesh, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com